ELOX · Eloxx Pharmaceuticals, Inc. · Share Buybacks
$13.30
+0.08 (+0.61%)
At close · Oct 21
Return incl. dividend (before tax)
Going-concern doubt
— cleared Aug 11, 2026
The latest filing no longer states the doubt (first flagged May 5, 2026).
View the 10-Q filed Aug 11, 2026Market Cap
$53.68M
Shares
4.04M
Volume · Oct 21
16.28K
Avg daily vol (3M)
43.03K
Share-repurchase activity from the company's own XBRL filings — cash spent on equity repurchases (common and preferred combined, as reported) per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Remaining Authorization
685,613 shares
as of 2026-06-30
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2010-06-30 | $-1,050,000 | 10-K/A, filed 2012-10-26 |